Friday, February 28, 2014

UNITE Group asking FDA to reconsider approving new pill



A coalition of health care and drug addiction treatment groups is urging the FDA to revoke approval of a new prescription drug.

UNITE is one of the groups that say Zohydro is a Hydrocodone-based painkiller that should not be allowed on the market.

They say pills' potential to become addictive will cause more harm than good.


Both Zohydro's maker and the FDA say the pill's benefits outweigh it's risks.